Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
1327345
Reference Type
Journal Article
Title
Restoration of p53 tumor suppressor pathway in human cervical carcinoma cells by sodium arsenite
Author(s)
Chou, RH; Huang, H
Year
2002
Is Peer Reviewed?
Yes
Journal
Biochemical and Biophysical Research Communications
ISSN:
0006-291X
EISSN:
1090-2104
Volume
293
Issue
1
Page Numbers
298-306
Language
English
PMID
12054599
DOI
10.1016/S0006-291X(02)00212-7
Web of Science Id
WOS:000175514700046
URL
http://linkinghub.elsevier.com/retrieve/pii/S0006291X02002127
Exit
Abstract
In most cervical cancer cells, p53 and Rb are disrupted by human papillomaviruses (HPVs) E6 and E7, respectively. Restoration of p53 or Rb function by blocking E6/p53 or E7/Rb pathway might be a potential therapeutic purpose for these cancer cells. Treatment with sodium arsenite (SA) resulted in significant repression of E6 and E7 mRNA levels in SiHa cells. After E6 and E7 repression, p53 was dramatically induced and accumulated in cellular nuclei and Rb was also induced. Two p53-responsive genes, p21(waf1/cip1) and mdm2, were induced after SA treatment. Furthermore, SA also reduced the expressions of Cdc25A and cyclin B, blocked cell cycle progression at G2/M phase, and induced apoptosis in SiHa cells. SA-induced apoptosis was greatly reduced by expression of a dominant-negative mutated p53. In this study, we have first demonstrated that SA did repress E6 and E7 oncogenes, restore the p53 tumor suppressor pathway and induce apoptosis in SiHa cells. Therefore, it would be a potential strategy to promote SA as therapeutic purpose for HPV-positive cancer cells.
Keywords
sodium arsenite; human papillomavirus; E6; E7; p53; Rb; apoptosis
Tags
IRIS
•
Arsenic (Inorganic)
1. Literature
PubMed
Toxline, TSCATS, & DART
Web of Science
4. Adverse Outcome Pathways/Networks Screening
Excluded/Not relevant
Title/Abstract screening
•
Arsenic MOA
1. MOA Literature Screening
MOA Cluster
3. Excluded
Other not relevant
Dragon Screened
•
Inorganic Arsenic (7440-38-2) [Final 2025]
1. Initial Lit Search
PubMed
WOS
ToxNet
4. Considered through Oct 2015
6. Cluster Filter through Oct 2015
iAs MOA Literature Categorization
Immune
Oxidative Stress
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity